fell 6% Friday despite a 34.5% first-quarter earnings gain.
The Duluth, Ga.-based company earned $37.7 million, or 42 cents a share, in the quarter, compared with $28 million, or 32 cents a share, a year ago. Analysts polled by Thomson First Call were expecting earnings of 39 cents a share in the most recent quarter.
First-quarter revenue rose 14.6% to $382.7 million as against analysts' expectation of $379.8 million.
The company expects earnings of 49 cents to 51 cents a share for the second quarter while analysts' estimate stands at 49 cents a share.
For the full year the company raised its guidance to $1.98 a share to $2.08 a share from $1.95 to $2.07 a share earlier. Analysts expect full year earnings of $2.02 a share.
The company's guidance does not include benefits from future acquisitions or the dilutive effects resulting from its convertible notes.
"Our recent acquisitions performed as expected in the quarter, and we completed the integration of Medtec and Civco into a single medical platform," the company said. "Many of our other businesses reported strong internal sales growth, including greater than 20% in our imaging segment."
The company's stock fell $2.82 to $47.28.
This story was created through a joint venture between TheStreet.com and IRIS.